top of page

 
業績｜論文・出版物｜目次｜
 

2013

Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human Laminin 111-coated dishes

Takayama K., Nagamoto Y., Mimura N., Tashiro K., Sakurai F., Tachibana M., Hayakawa T., Kawabata K., Mizuguchi H.

Stem Cell Rep., 1, 322-335 (2013)

PubMed

A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein

Matsui H., Sakurai F., Katayama K., Abe Y., Machitani M., Kurachi S., Tachibana M., Mizuguchi H.

Biomaterials, 34, 4191-4201 (2013)

PubMed

Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs

Machitani M., Sakurai F., Katayama K., Tachibana M., Suzuki T., Matsui H., Yamaguchi T., Mizuguchi H.

Virus Res., 178, 357-363 (2013)

PubMed

Novel polyvalent live vaccine against varicella-zoster and mumps virus infections

Matsuura M., Somboonthum P., Murakami K., Ota M., Shoji M., Kawabata K., Mizuguchi H., Gomi Y., Yamanishi K., Mori Y.

Microbiol Immunol., 57, 704-714 (2013)

PubMed

Ca2+ spiking activity caused by the activation of store-operated Ca2+ channels mediates TNF-α release from microglial cells under chronic purinergic stimulation

Ikeda M., Tsuno S., Sugiyama T., Hashimoto A., Yamoto K., Takeuchi K., Kishi H., Mizuguchi H., Kohsaka S-I, Yoshioka T.

Biochim. Biophys. Acta, 1833, 2573-2585 (2013)

PubMed

Regulation of IgE-dependent zinc release from human mast cells

Nakashima-Kaneda K., Matsuda A., Mizuguchi H., Sasaki-Sakamoto T., Saito H., Ra C., Okayama Y.

Int. Arch. Allergy. Immunol., 161, 44-51 (2013)

PubMed

3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing

Takayama K., Kawabata K., Nagamoto Y., Kishimoto K., Tashiro K., Sakurai F., Tachibana M., Kanda K.,Hayakawa T., Furue MK., Mizuguchi H.

Biomaterials, 34, 1781-1789 (2013)

PubMed

Gamma-delta T cells may function as carrier vehicles in adenovirus vector-based gene therapy

Naoe M., Ogawa Y., Hasebe Y., Iwamoto S., Mizuguchi H., Aoi T., Terao S.

J. Cancer Sci. Ther., 5, 384-390 (2013)

WebSite

NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites

Uchibori R., Tsukahara T., Mizuguchi H., Saga Y., Urabe M., Mizukami H., Kume A., Ozawa K.

Cancer Res., 73, 364-372 (2013)

PubMed

SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma

Iwahori K., Serada S., Fujimoto M., Ripley B., Nomura S., Mizuguchi H., Shimada K., Takahashi T., Kawase I., Kishimoto T., Naka T.

Int. J. Cancer, 132, 459-471 (2013)

PubMed

Two-step differentiation of mast cells from induced pluripotent stem cells

Yamaguchi T., Tashiro K., Tanaka S., Katayama S., Ishida W., Fukuda K., Fukushima A., Araki R., Abe M., Mizuguchi H., Kawabata K.

Stem Cell Dev., 22, 726-34 (2013)

PubMed

アデノウイルスベクターを利用したC型肝炎研究の新展開

吉田孟史, 近藤昌夫, 水口裕之, 八木清仁

薬学雑誌, 日本薬学会, 133, 305-31 (2013)

J-STAGE

次世代型制限増殖アデノウイルスを利用した血中循環がん細胞検出法の開発

櫻井文教, 藤原俊義, 水口裕之

薬学雑誌, 日本薬学会, 133, 291-296 (2013)

J-STAGE

ヒト多能性幹細胞から肝細胞への分化誘導法の開発とその毒性評価系への応用

高山和雄, 川端健二, 水口裕之

Tiss. Cult. Res. Commun., 32, 183–187 (2013)

J-STAGE

ヒトES/iPS細胞から肝細胞への高効率分化誘導法の開発とその創薬応用

高山和雄, 川端健二, 水口裕之

最新医学, 最新医学社, 68, 141-144 (2013)

CiNii

ヒトiPS 細胞由来分化誘導肝細胞を用いた薬物毒性評価系の開発

川端健二, 高山和雄, 水口裕之

BIO INDUSTRY, シーエムシー出版, 30, 19-24 (2013)

WebSite

遺伝子治療におけるDDS　ウイルスベクター

水口裕之

応用が拡がるDDS　人体環境から農業・家電まで, NTS (日本ハイコム (株)), 180-187 (2013)

WebSite

ヒトiPS細胞由来肝細胞を用いた毒性評価

水口裕之, 高山和雄, 川端健二

In vitro毒性・動態評価の最前線, シーエムシー出版, 63-70 (2013)

WebSite
bottom of page